Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of rett syndrome using glycyl-L-2-methylprolyl-L-glutamic acid

Treatment of rett syndrome using glycyl-L-2-methylprolyl-L-glutamic acid

US Patent 9212204 · Granted Dec 15, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicyclic compounds and methods for their use in treating Pitt Hopkins syndrome2025
Bicyclic compounds and methods for their use in treating autism2021
Bicyclic compounds and methods for their use in treating autism2021
Bicyclic compounds and methods for their use in treating autism2021
Bicyclic compounds and methods for their use in treating autism spectrum disorde2020
Bicyclic compounds and methods for their use in treating autism spectrum disorde2020
Bicyclic compounds and methods for their use in treating autism spectrum disorde2020
Neuroprotective bicyclic compounds and methods for their use in treating autism 2018
Neuroprotective bicyclic compounds and methods for their use in treating autism 2018
Neuroprotective bicyclic compounds and methods for their use in treating autism 2018
Treatment of fragile X syndrome using glycyl-L-2-methylprolyl-L-glutamate2017
Treatment of fragile X syndrome using glycyl-L-2-methylprolyl-L-glutamate2017